Other Income & Expense
Other Income (Expense)
Year-over-year, this metric declined by 131.4%, from $27.34M to -$8.59M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 177.4% CAGR.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Detailed definition
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Peer comparison
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
Metric ID:
other_income_expense_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $236.00K | $223.00K | $237.00K | $302.00K | $867.00K | $2.91M | $5.08M | $7.06M | $10.50M | $10.95M | $18.79M | $24.86M | $23.41M | $19.42M | $20.99M | $27.34M | $16.93M | $10.06M | $0.00 | -$8.59M |
| QoQ Change | — | -5.5% | +6.3% | +27.4% | +187.1% | +235.3% | +74.7% | +39.0% | +48.7% | +4.3% | +71.6% | +32.3% | -5.8% | -17.0% | +8.1% | +30.3% | -38.1% | -40.6% | -100.0% | — |
| YoY Change | — | — | — | — | +267.4% | >999% | >999% | >999% | >999% | +276.6% | +270.0% | +252.1% | +123.0% | +77.4% | +11.7% | +10.0% | -27.7% | -48.2% | -100.0% | -131.4% |
Range-$8.59M – $27.34M
CAGR+113.2%
Avg YoY Growth+473.5%
Median YoY Growth+187.5%
Current Streak4 quarters decline
Other Income (Expense) at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s other income (expense)?
- Revolution Medicines, Inc. (RVMD) reported other income (expense) of -$8.59M in Q1 2026.
- How has Revolution Medicines, Inc.'s other income (expense) changed year-over-year?
- Revolution Medicines, Inc.'s other income (expense) decreased by 131.4% year-over-year, from $27.34M to -$8.59M.
- What is the long-term trend for Revolution Medicines, Inc.'s other income (expense)?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s other income (expense) has grown at a 177.4% compound annual growth rate (CAGR), from $917.00K to $54.33M.
- What does other income (expense) mean?
- The net result of all income and expenses not related to core business operations.